Growth hormone promotes myelin repair after chronic hypoxia via triggering pericyte-dependent angiogenesis

Neuron. 2024 Jul 3;112(13):2177-2196.e6. doi: 10.1016/j.neuron.2024.03.026. Epub 2024 Apr 22.

Abstract

White matter injury (WMI) causes oligodendrocyte precursor cell (OPC) differentiation arrest and functional deficits, with no effective therapies to date. Here, we report increased expression of growth hormone (GH) in the hypoxic neonatal mouse brain, a model of WMI. GH treatment during or post hypoxic exposure rescues hypoxia-induced hypomyelination and promotes functional recovery in adolescent mice. Single-cell sequencing reveals that Ghr mRNA expression is highly enriched in vascular cells. Cell-lineage labeling and tracing identify the GHR-expressing vascular cells as a subpopulation of pericytes. These cells display tip-cell-like morphology with kinetic polarized filopodia revealed by two-photon live imaging and seemingly direct blood vessel branching and bridging. Gain-of-function and loss-of-function experiments indicate that GHR signaling in pericytes is sufficient to modulate angiogenesis in neonatal brains, which enhances OPC differentiation and myelination indirectly. These findings demonstrate that targeting GHR and/or downstream effectors may represent a promising therapeutic strategy for WMI.

Keywords: OPC; WMI; blood vessel; endothelia; myelin; myelination; white matter.

MeSH terms

  • Angiogenesis
  • Animals
  • Animals, Newborn
  • Cell Differentiation / drug effects
  • Growth Hormone / metabolism
  • Growth Hormone / pharmacology
  • Hypoxia / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Myelin Sheath* / metabolism
  • Neovascularization, Physiologic* / drug effects
  • Neovascularization, Physiologic* / physiology
  • Oligodendrocyte Precursor Cells / drug effects
  • Oligodendrocyte Precursor Cells / metabolism
  • Pericytes* / drug effects
  • Pericytes* / metabolism
  • Receptors, Somatotropin / genetics
  • Receptors, Somatotropin / metabolism

Substances

  • Growth Hormone
  • Receptors, Somatotropin